Endometrial Cancer Trial, Recruiting NCT07368205 Sponsor: University Hospital Hradec Kralove Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07368205
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older who have been newly diagnosed with endometrial (uterine) cancer, regardless of the specific type
  • People who are having surgery as the main treatment for their cancer
  • People who had an expert ultrasound and/or CT scan before surgery (though the CT scan may not be required in lower-risk cases)
  • People whose cancer was assessed before surgery as being at an early stage (stage I or II)
  • People for whom a technique called sentinel lymph node mapping was attempted during their surgery (this is a procedure to check nearby lymph nodes for cancer)
  • People for whom a preserved tissue sample from their biopsy is available for laboratory testing
  • People who have signed a consent form agreeing to take part in the study

Who may not be able to join:

  • People who received treatment (such as chemotherapy or radiation) before surgery to shrink the cancer
  • People whose cancer had already spread to other parts of the body at the time of diagnosis, or whose cancer had come back after a previous diagnosis
  • People whose imaging scans or tissue samples are not sufficient for the study's requirements
  • People who have two separate primary cancers occurring at the same time (confirm with trial site)
  • People who have had any cancer treatment within the last five years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Hradec Kralove
Registry
ClinicalTrials.gov
Start date
15 February 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

The accuracy of preoperative risk stratification; Determination of specific groups for whom: 1) lymph node staging is crucial for changing risk category and adjuvant treatment decisions, and 2) lymph node staging could be safely omitted

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov